Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases

Video Author:Lisa S.M. Hofste, M.Sc. • Maartje J. Geerlings, Ph.D. • Eveline J. Kamping, B.Sc. • Nadine D.H. Kouwenhoven, M.Sc. • Daniel von Rhein, Ph.D. • Erik A.M. Jansen, B.Sc. • Linda M. Garms, B.Sc. • Iris D. Nagtegaal, M.D., Ph.D. • Rachel S. van der Post, M.D.,

Published on:May 23, 2023

Associated with:

Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases July 2022

These data indicate that tumor-informed circulating tumor DNA detection in the plasma of patients undergoing surgery for metastatic colorectal cancer is feasible and may have clinical value in response monitoring and predicting residual disease. Prospective studies are needed to establish the clinical utility of circulating tumor DNA analysis to guide treatment decisions in these patients.

Secondary Logo

Journal Logo

Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases

Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases

Laparoscopic Extended Total Pelvic Exenteration with En bloc Penectomy with Minimally Invasive Mucosal Removal Sigmoid Flap Pelvic Reconstruction for T4 Rectal Cancer

2017 ASCRS Annual Meeting Best Video, Martius Flap for Persistent, Complex Rectovaginal Fistula (Kaminski et al.)

Video Vignette: September 2022

2018 ASCRS Barton Hoexter, MD, Best Video Award. Redo repair of a recurrent rectovaginal fistula with rectal advancement flap: three-layer closure.

Transanal Endoscopic Operation (TEO) approach to mesorectal lesions: Local excision of lymph node metastasis of neuroendocrine tumor.